Kastelein R - Search Results

1

Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.

Cai G, Radzanowski T, Villegas EN, Kastelein R, Hunter CA. Cai G, et al. Among authors: kastelein r. J Immunol. 2000 Sep 1;165(5):2619-27. doi: 10.4049/jimmunol.165.5.2619. J Immunol. 2000. PMID: 10946290

2

IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12.

Lieberman LA, Cardillo F, Owyang AM, Rennick DM, Cua DJ, Kastelein RA, Hunter CA. Lieberman LA, et al. J Immunol. 2004 Aug 1;173(3):1887-93. doi: 10.4049/jimmunol.173.3.1887. J Immunol. 2004. PMID: 15265921

3

IL-27 limits IL-2 production during Th1 differentiation.

Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, Hunter CA. Villarino AV, et al. J Immunol. 2006 Jan 1;176(1):237-47. doi: 10.4049/jimmunol.176.1.237. J Immunol. 2006. PMID: 16365415

4

Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer.

Hunter CA, Timans J, Pisacane P, Menon S, Cai G, Walker W, Aste-Amezaga M, Chizzonite R, Bazan JF, Kastelein RA. Hunter CA, et al. Among authors: kastelein ra. Eur J Immunol. 1997 Nov;27(11):2787-92. doi: 10.1002/eji.1830271107. Eur J Immunol. 1997. PMID: 9394800

5

IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma.

Walker W, Aste-Amezaga M, Kastelein RA, Trinchieri G, Hunter CA. Walker W, et al. Among authors: kastelein ra. J Immunol. 1999 May 15;162(10):5894-901. J Immunol. 1999. PMID: 10229825

6

IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18.

Cai G, Kastelein RA, Hunter CA. Cai G, et al. Among authors: kastelein ra. Eur J Immunol. 1999 Sep;29(9):2658-65. doi: 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.0.CO;2-G. Eur J Immunol. 1999. PMID: 10508240 Free article.

7

Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii.

Cai G, Kastelein R, Hunter CA. Cai G, et al. Among authors: kastelein r. Infect Immun. 2000 Dec;68(12):6932-8. doi: 10.1128/IAI.68.12.6932-6938.2000. Infect Immun. 2000. PMID: 11083816 Free PMC article.

8

Interleukin-27: balancing protective and pathological immunity.

Hunter CA, Kastelein R. Hunter CA, et al. Among authors: kastelein r. Immunity. 2012 Dec 14;37(6):960-9. doi: 10.1016/j.immuni.2012.11.003. Immunity. 2012. PMID: 23244718 Free PMC article. Review.

9

New paradigms in inflammation: where to next?

Hunter CA, Kastelein R. Hunter CA, et al. Among authors: kastelein r. Immunol Rev. 2008 Dec;226:6-9. doi: 10.1111/j.1600-065X.2008.00716.x. Immunol Rev. 2008. PMID: 19161411 No abstract available.

10

The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection.

Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, Yoshida H, Kastelein RA, Saris C, Hunter CA. Villarino A, et al. Immunity. 2003 Nov;19(5):645-55. doi: 10.1016/s1074-7613(03)00300-5. Immunity. 2003. PMID: 14614852 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page